ArticleNeuro-oncology2020

Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.

Catherine Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.